Showing results (231-240 of 362) with videos related to

Sort By:
Pageof 37
Clinical Pharmacology and Therapeutics|December 1, 1983
Differential stereoselective metabolism of metoprolol in extensive and poor debrisoquin metabolizersM S Lennard, G T Tucker, J H Silas, et al.
Antibiotics (Basel, Switzerland)|July 2, 2021
Systems Biology and Bile Acid Signalling in Microbiome-Host Interactions in the Cystic Fibrosis LungDavid F Woods, Stephanie Flynn, Jose A Caparrós-Martín, et al.
British Journal of Clinical Pharmacology|June 1, 1984
The relationship between debrisoquine oxidation phenotype and the pharmacokinetics and pharmacodynamics of propranololM S Lennard, P R Jackson, S Freestone, et al.
Journal of Agricultural and Food Chemistry|March 4, 2010
Encapsulation of plant oils in porous starch microspheresGregory M Glenn, Artur P Klamczynski, Delilah F Woods, et al.
Journal of Molecular and Cellular Cardiology Plus|December 11, 2025
Insulin use promotes pro-inflammatory changes in the transcriptome of atherosclerotic plaques in patients with diabetes mellitusAngelle Bradford, Tadashi Yoshida, Sergiy Sukhanov, et al.
EDTNA/ERCA Journal (English Ed.)|July 7, 1999
Low seroconversion for hepatitis C virus (HCV) antibody achieved by universal precautions aloneA Flett, M Teo, Y I Mah, et al.
Climacteric : the Journal of the International Menopause Society|August 14, 2013
Effects of mind-body therapies on symptom clusters during the menopausal transitionN F Woods, E S Mitchell, J G Schnall, et al.
British Journal of Clinical Pharmacology|January 1, 1984
Effects of beta-adrenoceptor antagonists on the pharmacokinetics of lignocaineG T Tucker, N D Bax, M S Lennard, et al.
Climacteric : the Journal of the International Menopause Society|March 11, 2014
Effects of herbal preparations on symptom clusters during the menopausal transitionR Ismail, L Taylor-Swanson, A Thomas, et al.
Pageof 37